All Access Articles |
- Arbutus Biopharma Q3 2025 Results - $28.9M Liquidity Decline | 2025-11-13 | PHARMACEUTICAL
- Arbutus Biopharma Regains Global Rights for Imdusiran | 2025-06-25 | PHARMACEUTICAL
- Arbutus Biopharma appoints new CEO and board members | 2025-02-25 | PHARMACEUTICAL
- Arbutus Biopharma Achieves 50% Functional Cure in Hepatitis B Trial | 2024-11-15 | PHARMACEUTICAL